CD14 and neoplasm: Specific to MSS tumours, CD14 had a FC of 0.66 compared to a FC of 0.68 overall and CSNK2A1 had a FC of 1.54 for MSS tumours compared to 1.49 overall (Supplemental Table 2 for MSS results).